Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026)
Pharvaris (PHVS) reported Other Working Capital Changes of -$1.4 million for Q1 2026, down 5.38% on a YoY basis from -$1.5 million in Q1 2025, and down 711.56% quarter-over-quarter from $234668.8 in Q4 2025.
Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Pharvaris has reported Other Working Capital Changes for 6 years, with the latest figure at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 5.38% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 billion (up 122.12% YoY), and the FY2025 full-year result was $2.0 million, up 1436.23% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.4 million, down from $234668.8 in the prior quarter.
- The five-year high for Other Working Capital Changes was $5285.8 billion in Q3 2023, with the low at -$5287.4 billion in Q2 2023.
- Historically, Other Working Capital Changes has averaged $1.1 billion across 5 years, with a median of -$1.4 million in 2025.
- The largest YoY upside for Other Working Capital Changes was 1412968002.67% in 2023 against a maximum downside of 695583948.37% in 2023.
- Pharvaris' Other Working Capital Changes stood at -$325334.4 in 2022, then jumped by 1512.62% to $4.6 million in 2023, then sank by 132.72% to -$1.5 million in 2024, then soared by 115.6% to $234668.8 in 2025, then tumbled by 711.56% to -$1.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q1 2026), $234668.8 (Q4 2025), and $448.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | 234,668.84 |
| Dec 31, 2025 | 234,668.84 |
| Sep 30, 2025 | 448.46 Bn |
| Sep 30, 2025 | 448.46 Bn |
| Jun 30, 2025 | -434.23 Bn |
| Jun 30, 2025 | -434.23 Bn |
| Mar 31, 2025 | -1.36 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 329.84 Bn |
| Sep 30, 2024 | 329.84 Bn |
| Jun 30, 2024 | -323.43 Bn |
| Jun 30, 2024 | -323.43 Bn |
| Mar 31, 2024 | -2.19 Mn |
| Mar 31, 2024 | -2.19 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Dec 31, 2023 | 4.60 Mn |